{"data":[{"id":"2429ef6c-9971-4989-99c4-c87b054ec133","company_name":"京都大学","company_name_en":null,"corporate_number":null,"authority":"厚生労働省","authorities":["厚生労働省"],"authority_count":1,"action_types":["指定"],"regional_record_count":1,"source_document_count":1,"law_name":"薬機法","action_type":"指定","action_date":"2017-02-28","announcement_date":"2026-05-02","violation_summary":"非自己iPS細胞由来ドパミン神経前駆細胞を用いたパーキンソン病治療であり、従来の治療法とは異なる作用機序を有する。","violation_summary_en":"The Ministry of Health, Labour and Welfare designated Kyoto University under the Pharmaceutical and Medical Device Act on February 28, 2017, for using non-autologous iPS cell-derived dopamine neuron precursor cells in Parkinson's disease treatment, which has a different mechanism of action from conventional therapies.","penalty_amount":null,"is_verified":false,"record_verified":false,"entity_match":{"status":"unresolved","confidence":60,"method":"extracted_japanese_name","notes":"A current-policy Corporate Number match to a verified company profile is not available."},"human_review_status":"unreviewed","source_url":"https://www.mhlw.go.jp/stf/houdou/0000153128.html","url":"https://regbase.jp/enforcement/yakkiho-jing-du-da-xue-20170228"}],"meta":{"query":"京都大学","corporate_number":null,"law":null,"authority":null,"action_type":null,"count":1,"api_docs":"https://regbase.jp/api-docs","openapi_schema":"https://regbase.jp/api/openapi.json","llms":"https://regbase.jp/llms.txt","usage_note":"Use RegBase for targeted public-source screening of Japanese companies and enforcement records. Absence of returned records is not a clearance, legal opinion, sanctions result, or credit decision.","rate_limit":{"limit":10,"window_seconds":60,"remaining":7,"reset_at":"2026-08-04T18:34:24.336Z"},"daily_rate_limit":{"limit":300,"window_seconds":86400,"remaining":65,"reset_at":"2026-08-05T18:33:24.336Z"}}}